3262 related articles for article (PubMed ID: 6850464)
1. Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humans.
Falk RE; Makowka L; Ambus U; Falk JA; Bugala R; Landi S
Can Med Assoc J; 1983 Jun; 128(12):1385-8, 1422. PubMed ID: 6850464
[TBL] [Abstract][Full Text] [Related]
2. Immunostimulation with intraperitoneally administered bacille Calmette Guérin for advanced malignant tumors of the gastrointestinal tract.
Falk RE; MacGregor AB; Landi S; Ambus U; Langer B
Surg Gynecol Obstet; 1976 Mar; 142(3):363-8. PubMed ID: 1251316
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemoimmunotherapy for gastric carcinoma.
Makowka L; Falk RE; Ambus U; Bugala R; Landi S
Can J Surg; 1980 Sep; 23(5):429-31. PubMed ID: 6159957
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
5. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
6. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
Agarwala SS; Neuberg D; Park Y; Kirkwood JM
Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
[TBL] [Abstract][Full Text] [Related]
7. Oral bacille Calmette Guérin immunostimulation in malignant melanoma.
MacGregor AB; Falk RE; Landi S; Ambus U; Langer B
Surg Gynecol Obstet; 1975 Nov; 141(5):747-54. PubMed ID: 1105837
[TBL] [Abstract][Full Text] [Related]
8. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.
Kölmel KF; Grange JM; Krone B; Mastrangelo G; Rossi CR; Henz BM; Seebacher C; Botev IN; Niin M; Lambert D; Shafir R; Kokoschka EM; Kleeberg UR; Gefeller O; Pfahlberg A
Eur J Cancer; 2005 Jan; 41(1):118-25. PubMed ID: 15617996
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
Grigorovich NA; Risina DIa; Nodel'son SE
Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396
[TBL] [Abstract][Full Text] [Related]
10. A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin in patients with metastatic cancer.
O'Connell MJ; Ritts RE; Moertel CG; O'Fallon JR; Rubin J; Frytak S; Schutt AJ
Cancer Clin Trials; 1981; 4(4):439-49. PubMed ID: 6459190
[TBL] [Abstract][Full Text] [Related]
11. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of chemoimmunotherapy for resectable and non-resectable gastrointestinal cancer.
Ambus U; Falk RE; Landi S; Bugala R; Langer B
Dev Biol Stand; 1977 Apr 13-15; 38():541-5. PubMed ID: 344107
[TBL] [Abstract][Full Text] [Related]
13. [Disseminated breast carcinoma. Study of activity of immunotherapy with BCG and duration of the phase of intensive chemotherapy. Results of a randomized trial (author's transl)].
Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H; Asselain B
Bull Cancer; 1981; 68(1):6-18. PubMed ID: 7013868
[TBL] [Abstract][Full Text] [Related]
14. Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guérin in patients with high-risk bladder cancer.
Gårdmark T; Jahnson S; Wahlquist R; Wijkström H; Malmström PU
BJU Int; 2007 Apr; 99(4):817-20. PubMed ID: 17244282
[TBL] [Abstract][Full Text] [Related]
15. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
Giaccone G; Debruyne C; Felip E; Chapman PB; Grant SC; Millward M; Thiberville L; D'addario G; Coens C; Rome LS; Zatloukal P; Masso O; Legrand C
J Clin Oncol; 2005 Oct; 23(28):6854-64. PubMed ID: 16192577
[TBL] [Abstract][Full Text] [Related]
16. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
Winters WD; Lamm DL
Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
[TBL] [Abstract][Full Text] [Related]
19. Clinical study of bladder cancer: Proteinuria as a predictor of recurrence and efficacy of intravesical bacille Calmette-Guerin therapy.
Satoh A; Hanawa Y; Nakamura S
Int J Urol; 2004 Jul; 11(7):476-82. PubMed ID: 15242355
[TBL] [Abstract][Full Text] [Related]
20. Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study.
Yoneyama T; Ohyama C; Imai A; Ishimura H; Hagisawa S; Iwabuchi I; Mori K; Kamimura N; Koie T; Yamato T; Suzuki T
Urology; 2008 Jun; 71(6):1161-5. PubMed ID: 18279920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
